Begin main content

von Willebrand Factor [recombinant]

Last Updated: January 2, 2020
Result type: Reports
Project Number: ST0639-001
Product Line: Common Drug Review

Generic Name: von Willebrand Factor [recombinant]

Brand Name: Vonvendi

Manufacturer: Shire Pharma Canada ULC, now part of Takeda

Indications: von Willebrand disease, adults (perioperative management)

Submission Type: New

Project Status: Pending

Call For Patient Input: January 2, 2020

Patient Input Closed: February 21, 2020

Anticipated Date: January 30, 2020

Fee Schedule: Pending

Submit Feedback